Celgene Corporation
(NASDAQ : CELG)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
TSROTESARO, Inc.
0.16%73.7814.4%$592.28m
AMGNAmgen Inc.
-0.08%189.931.2%$550.85m
GILDGilead Sciences, Inc.
1.01%65.780.9%$540.87m
CELGCelgene Corporation
0.15%68.231.2%$494.67m
ILMNIllumina, Inc.
1.64%316.003.5%$345.12m
BIIBBiogen Inc.
-3.00%303.721.3%$345.06m
REGNRegeneron Pharmaceuticals, Inc.
0.39%376.972.6%$270.13m
AAgilent Technologies, Inc.
1.19%68.661.5%$217.10m
VRTXVertex Pharmaceuticals Incorporated
1.23%168.211.9%$216.00m
ALXNAlexion Pharmaceuticals, Inc.
0.09%109.632.0%$153.97m
INCYIncyte Corporation
1.03%65.492.5%$98.18m
EXASExact Sciences Corporation
0.34%67.3425.3%$94.02m
BLUEBluebird Bio, Inc.
-2.26%102.2114.4%$85.55m
SRPTSarepta Therapeutics, Inc.
0.02%115.7215.4%$84.47m
GBTGlobal Blood Therapeutics Inc
0.12%41.627.0%$80.94m

Company Profile

Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its targeting areas include intracellular signaling pathways, protein homeostasis and epigenetics in cancer and immune cells, immunomodulation in cancer and autoimmune diseases and therapeutic application of cell therapies. The company's products include Revlimid, Vidaza, Thalomid, Pomalyst/Imnovid, Abraxane, and Istodax. Celgene was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.